Panda Surgical

Executive Summary

Panda Surgical is a UK-based developer of a next-generation handheld robotics platform designed to enhance neurosurgeon dexterity and control in confined surgical spaces. The system aims to enable more surgeons to perform complex minimally invasive procedures, addressing a critical need in neurosurgery where precision and access are paramount. Founded in 2016, the company is currently at the pre-clinical stage, focusing on refining its technology and preparing for first-in-human studies. The platform's unique handheld form factor differentiates it from larger, more expensive robotic systems, potentially democratizing access to advanced surgical robotics across smaller hospitals and clinics globally. The global neurosurgery robotics market is growing, driven by demand for less invasive techniques and improved patient outcomes. Panda Surgical's technology could play a key role in this evolution, provided it successfully navigates clinical development and regulatory hurdles. With its innovative approach, the company has the potential to capture significant market share, but as a pre-clinical entity, it faces substantial execution risks, including funding, regulatory, and technical challenges.

Upcoming Catalysts (preview)

• Q1 2027First-in-human clinical trial initiation40% success
• Q2 2026Series A funding round60% success
• Q4 2026CE mark submission for European market35% success